Monday, December 22, 2014

Breast Cancer

  • More Top Stories
  • Latest News
Cost a key factor for women to maintain hormone treatment regimen, researchers report
October is Breast Cancer Awareness Month - and a call to action to get your annual breast checkup.
A blood test under development at the Johns Hopkins University could reduce the number of women who need chemotherapy significantly by revealing who has residual cancer cells after surgery to remove the tumors.
Some say it’s the hardest thing they have ever had to hear, but for Shelley Crenshaw, three-time breast cancer survivor, it was a blessing.
Next month, Thomas G. Frazier will sit down with colleagues at Bryn Mawr Hospital's Comprehensive Breast Center and unseal the results of a blind study for Dune Medical's MarginProbe.
Q: How often should I be screened for breast cancer? A: Breast cancer is the second-leading cancer killer of women. Early detection with screening mammography is key because treatment can be started earlier in the course of the disease.
There are some people who are not uplifted by Breast Cancer Awareness Month, including some who are breast cancer patients.
Proper diet, exercise, weight control among factors that may help, experts say
With arrival of October comes plenty of pink on everything everywhere as part of Breast Cancer Awareness Month. So what better time to raise awareness about what’s helpful — and what’s not — when a friend, family member or acquaintance has cancer?
Agency also gives OK to genetic test used to identify eligible patients
Agency also gives OK to genetic test used to identify eligible patients
Since both involve hormone levels, researchers suspected a possible connection
Idea is to identify women who do and don't need further treatment
Women without estrogen-dependent disease benefited most in study
Suppressing the ovaries and adding an anti-estrogen drug reduced recurrence in premenopausal women
Studies show that a shorter course of treatment yields similar benefits, but it remains underused, experts say
Combination treatment for estrogen-receptor-positive tumors shows promise, researchers say
Men's tumor types differ; survival is increasing but not as much as for women, study finds
Study finds test after normal mammogram saves few lives while boosting costs and false-positive results
Conditions such as depression or schizophrenia linked to lower mammogram rates
Limiting screening to women with family history, dense breasts would miss many cancers, researchers find
Injection boosted immune response, seemed to slow spread in those with advanced disease
Largest number of obesity-related cancers diagnosed in North America and Europe, researchers report